The Alzheimer's Association is lobbying Congress to enable early Medicare coverage of a new class of drugs, beginning with Leqembi, which promise to slow the spreading of the disease in patients.
The Alzheimer's Association is lobbying Congress to enable early Medicare coverage of a new class of drugs, beginning with Leqembi, which promise to slow the spreading of the disease in patients.
/PRNewswire/ While recent advancements in treatment of early-stage Alzheimer s, including mild cognitive impairment (MCI) due to Alzheimer s disease, are.